Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Timely Intervention: Advances in the Treatment of Relapsing Remitting Multiple Sclerosis
Madrid, Spain / September 27-30, 2006
Madrid - Multiple sclerosis (MS) is the most common progressive and debilitating neurological disease in young adults, affecting approximately 50,000 people in Canada. Emerging evidence from longitudinal studies confirms that early MRI...
22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Evolving Treatment Options for Multiple Sclerosis
Madrid, Spain / September 27-30, 2006
Madrid - Despite the advent of several promising new agents currently in development, established first-line therapies for multiple sclerosis (MS), i.e. glatiramer acetate (GA) and interferon b (IFNb), continue to dominate treatment trials....
16th Migraine Trust International Symposium
Migraine Research: From Bench to Patient
London, UK / September 18-20, 2006
According to Dr. Hans-Christoph Diener, Chairman, Department of Neurology, University of Essen, Germany, all studies of single agents for pain therapy should be placebo-controlled. This allows indirect comparisons between trials and is...
5th Congress of the European Federation of IASP Chapters
Pain and Pain-associated Sleep Disturbances: Maximizing Treatment Outcomes
Istanbul, Turkey / September 13-16, 2006
Dr. Stephen Gibson, Director of Research, Caulfield Pain Management and Research Centre, Victoria, Australia, noted that in the elderly there is a decline in the sensitivity to pain, but there is also a reduced tolerance to severe pain....
48th Annual Scientific Meeting of the American Headache Society
New Directions in Migraine Therapies for Women: Update on the Role of Triptans
Los Angeles, California / June 22-25, 2006
Women’s issues regarding migraines were at the forefront during the scientific sessions here this week. Dr. Stephen Silberstein, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, and President of the American Headache...
16th European Meeting on Hypertension
The Role of Angiotensin II Antagonism in Stroke Prevention
Madrid, Spain / June 12-15, 2006
Madrid - Angiotensin II antagonists (AIIAs) have become an important option for treating hypertension. Recent data were represented here during the scientific sessions that further confirm their efficacy in lowering blood pressure (BP),...
42nd Annual Meeting of the American Society of Clinical Oncology
Progress in the Search for Improved Prognosis in Malignant Glioma
Atlanta, Georgia / June 2-6, 2006
Atlanta - Brain tumours account for only 1.5% of all cancers but cause substantial morbidity and mortality. The American Cancer Society estimates that approximately 19,000 malignant brain tumours are diagnosed in the US each year, and...
Sixteenth Meeting of the European Neurological Society
Novel Long-term Data from Early Multiple Sclerosis Analysis: Corroborative Evidence
Lausanne, Switzerland / May 27-31, 2006
Lausanne - The current disease-modifying treatments (DMTs) authorized for multiple sclerosis (MS) are interferon beta (IFNß) therapy and glatiramer acetate. Experts here at the meeting presented new studies with IFNß-1b, the first DMT to be...
58th Annual Meeting of the American Academy of Neurology
Contemporary Issues in Multiple Sclerosis: New Perspectives and Strategies
San Diego, California / April 1-8, 2006
San Diego - The development of neutralizing antibodies to interferon beta (IFNß) is well recognized but new research suggests that other mechanisms may also play an important role in diminishing the activity of IFNß in patients with...